WALTHAM, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the launch of AVIPure ® dsRNA ...
Repligen (RGEN) announced the launch of AVIPure dsRNA Clear OPUS columns, a solution designed to simplify and enhance the production of mRNA therapeutics and vaccines. This novel affinity ...
Breakthrough Innovation for the Purification of mRNA Therapeutics and Vaccines WALTHAM, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results